Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | How GvHD impacts patient quality of life

In this video, Shernan Holtan, MD, University of Minnesota, Minneapolis, MN, briefly explains how graft-versus-host disease (GvHD) can affect a patient’s quality of life (QoL). GvHD can result in mobility issues, an increased risk of infection, and other serious complications, and Dr Holtan further highlights the importance of analyzing QoL data in ongoing clinical trials. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Incyte: Research Funding; Vitrac Therapeutics: Research Funding; CSL Behring: Other: Clinical trial adjudication.